Jupiter Wellness, Inc. (JUPW) Bundle
Jupiter Wellness, Inc. (ticker: JUPW) is a publicly traded U.S. wellness company whose shares last traded at $0.3917 (down $0.03, -0.07%) with an open of $0.40, intraday high/low of $0.439/$0.3703, intraday volume of 13,958,898, and last trade reported on Thursday, October 9 at 17:15 PDT, tracing a corporate arc that began on October 24, 2018 as CBD Brands, Inc., pivoted in August 2023 via acquisition of GBB Drink Lab Inc. assets to rebrand as Safety Shot, Inc. (formerly trading as SHOT), launched the Sure Shot dietary supplement in December 2023, and by 2025 sponsored Jupiter Wellness Acquisition Corp., a SPAC targeting AI in medical therapeutics aiming to raise $100 million that successfully completed and began trading as CJET-moves that underscore a strategy blending OTC product development, patent-protected IP, and strategic licensing; the company reports investing about $1.2 million annually in R&D (approximately 15% of its revenue) to target underserved conditions like hair loss, eczema, burns and sexual wellness, monetizing through product sales, contract research, and licensing deals (including a partnership for its Minoxidil Booster with Taisho, a company with reported revenue of $2.6 billion), while concurrently disclosing accumulated deficits and cash flow used in operations as it expands international launches such as Photocil in India and pursues further strategic alliances.
Jupiter Wellness, Inc. (JUPW) - Intro
Jupiter Wellness, Inc. (JUPW) is a U.S.-listed equity focused on wellness, health services, and consumer health brands. The company combines product development, brand acquisition, and distribution channels to pursue revenue growth across supplements, telehealth, and ancillary wellness services.
- Ticker: JUPW
- Market: United States equity market
- Primary focus: consumer wellness products, telehealth-enabled services, and brand roll-ups
| Metric | Value |
|---|---|
| Last trade price | $0.3917 |
| Change (USD / %) | -$0.03 (-0.07%) |
| Open | $0.40 |
| Intraday high | $0.439 |
| Intraday low | $0.3703 |
| Intraday volume | 13,958,898 |
| Latest trade time | Thursday, October 9, 17:15:00 PDT |
History & Corporate Development
- Founding and evolution: Jupiter Wellness began as a specialty consumer health player and evolved through acquisitions and partnerships to broaden product lines and service offerings.
- Acquisition strategy: Historically pursued roll-ups of complementary brands to scale distribution, reduce per-unit marketing costs, and cross-sell product lines.
- Recent corporate actions: Active in brand consolidation, supply-chain optimization, and expanding direct-to-consumer (DTC) channels to improve gross margins.
Ownership & Governance
- Shareholder base: Typically a mix of retail investors, smaller institutional positions, and insider holdings (founders/executive ownership may be material in micro-/small-cap wellness firms).
- Board & management: Operates with a board overseeing M&A and capital allocation; management focus on integration of acquired brands and scaling digital channels.
Mission, Vision & Core Values
Jupiter Wellness positions itself as a consumer-centric wellness company that emphasizes accessible, science-backed products and integrated service offerings to improve health outcomes.
- Mission: Deliver evidence-informed wellness products and services that are accessible and affordable.
- Vision: Become a leading aggregated platform for wellness brands and telehealth services in North America.
- Core values: Consumer safety, product transparency, scalable distribution, and measurable health outcomes.
More on corporate mission and long-range strategy: Mission Statement, Vision, & Core Values (2026) of Jupiter Wellness, Inc.
How Jupiter Wellness, Inc. Works
- Business model: Acquire and integrate consumer wellness brands, optimize supply chains, and drive DTC and retail distribution.
- Channels: Direct-to-consumer websites, third-party marketplaces, specialty retail, and telehealth portals where applicable.
- Product focus: Supplements, over-the-counter wellness products, and subscription-based health regimens.
- Operational levers: SKU rationalization, centralized logistics, digital marketing scale, and cross-brand promotions.
How It Makes Money (Revenue Streams)
- Product sales - DTC: One-time purchases and subscription models for repeat revenue.
- Wholesale & retail distribution: Bulk sales to retailers and specialty channels.
- Telehealth and service fees: Fees for telemedicine consults, personalized plans, or partner services (where offered).
- Licensing & white-labeling: Licensing proprietary formulas or manufacturing for third parties.
Key Financial & Market Indicators (Operational Focus)
- Price and liquidity: Current price $0.3917 with intraday volume of 13,958,898 - indicative of active retail trading on the session cited.
- Volatility indicators: Intraday range from $0.3703 to $0.439 on the latest session, showing notable intraday movement relative to price level.
- Capital strategy: Growth typically funded via equity raises, debt facilities for acquisitions, or seller-financed deals in roll-up scenarios.
| Area | Why it matters |
|---|---|
| Price & Volume | Reflects market sentiment, liquidity and potential retail interest; last trade at $0.3917 with 13,958,898 shares traded. |
| Intraday range | $0.3703 - $0.439 shows short-term volatility and trader activity on the cited date/time. |
| Revenue model | DTC subscriptions + wholesale + services provide diversified revenue channels and potential for margin expansion. |
| Growth drivers | Brand acquisitions, digital marketing scale, and improved unit economics from consolidated operations. |
Jupiter Wellness, Inc. (JUPW): History
Jupiter Wellness, Inc. (JUPW) traces its corporate evolution from a CBD therapeutics developer into a diversified health-and-wellness company with strategic acquisitions and capital-marketing transactions.- Founded on October 24, 2018 as CBD Brands, Inc., with an initial focus on cannabidiol (CBD) medical therapeutics and wellness products.
- August 2023: acquired certain assets of GBB Drink Lab Inc., including the blood alcohol detox drink Sure Shot; corporate name changed to Safety Shot, Inc.; NASDAQ ticker: SHOT.
- December 2023: launched the Sure Shot Dietary Supplement, entering the health & wellness beverage market.
- 2025: sponsored Jupiter Wellness Acquisition Corp., a SPAC targeting AI in medical therapeutics and diagnostics, with an initial fundraising target of $100 million.
- Following SPAC completion, the new operating entity began trading on NASDAQ under ticker CJET, signaling a pivot to AI-enabled medical solutions while continuing wellness product expansion.
- Late 2025: ongoing efforts to expand product portfolio and market presence across health & wellness channels.
| Key Date | Event | Ticker / Amount |
|---|---|---|
| 2018-10-24 | Incorporation as CBD Brands, Inc. | N/A |
| 2023-08 | Asset acquisition from GBB Drink Lab Inc.; rebrand to Safety Shot, Inc. | NASDAQ: SHOT |
| 2023-12 | Sure Shot Dietary Supplement launch | Product launch |
| 2025 | Sponsored SPAC (Jupiter Wellness Acquisition Corp.) targeting AI in therapeutics/diagnostics | Target raise: $100,000,000 |
| 2025 (post-SPAC) | New entity begins NASDAQ trading | NASDAQ: CJET |
- Core strategic thrusts: product commercialization (Sure Shot and related wellness SKUs), technology-driven M&A via SPAC, and market listing strategies to access capital for R&D and distribution.
- Revenue model drivers include direct-to-consumer supplement sales, wholesale/beverage channel partnerships, and potential licensing or AI-enabled diagnostics commercialization via the CJET vehicle.
Jupiter Wellness, Inc. (JUPW): Ownership Structure
- Ticker history: originally traded as JUPW on NASDAQ; after acquisition of GBB Drink Lab Inc., the company changed its name to Safety Shot, Inc. in August 2023 and began trading under SHOT.
- SPAC activity: in 2025 Jupiter Wellness sponsored Jupiter Wellness Acquisition Corp., which commenced trading on NASDAQ under ticker CJET; the SPAC transaction completed and the new entity now trades on NASDAQ as part of Jupiter's strategic initiatives.
- Public ownership: shares are held by a mix of institutional investors and individual (retail) shareholders, with insider holdings from officers and early investors.
| Item | Detail / Approximate Value |
|---|---|
| NASDAQ tickers (historic/current) | JUPW → SHOT (post-Aug 2023); CJET (SPAC sponsor vehicle, 2025) |
| Institutional ownership (approx.) | ~50-65% of float |
| Retail/individual ownership (approx.) | ~25-40% of float |
| Insider ownership (founders/officers) | ~5-15% |
| Reported accumulated deficit | Material accumulated deficit reported on public filings (company-level) |
| Cash flow from operations | Negative operating cash flow reported in recent periods (operational cash burn noted) |
- Capital structure & funding: public equity is the primary source of capital post-listing and SPAC activity; the company has used equity raises and transaction proceeds tied to the Safety Shot rebranding and the SPAC to fund operations and strategic acquisitions.
- Governance: as a NASDAQ-listed entity, the company is subject to public-company governance standards-board oversight, SEC reporting (10-Q/10-K), and shareholder voting-affecting control dynamics between institutional holders and retail investors.
- Financial health signals: accumulation of deficits and continued use of cash in operations, as disclosed in filings, highlight liquidity and sustainability questions for investors considering exposure to SHOT/CJET-related securities.
Jupiter Wellness, Inc. (JUPW): Mission and Values
Jupiter Wellness is dedicated to advancing health and wellness through the development of innovative, evidence-based products targeted at underserved conditions. The company centers its strategy on research-driven product development, intellectual property protection, and strategic partnerships to expand market reach and improve patient outcomes.- Core mission: Develop safe, effective therapies for underserved health needs via rigorous R&D and clinical validation.
- Core values: scientific integrity, patient-centric development, continuous improvement, ethical commercialization, and collaborative partnerships.
- Target therapeutic focus areas: hair loss, eczema, burns, and sexual wellness.
- Annual R&D investment: approximately $1.2 million.
- R&D as share of revenue: ~15%, implying annual revenue on the order of $8 million.
- Intellectual property: maintains a diverse portfolio of granted and pending patents to protect formulations, delivery technologies, and clinical applications.
- Revenue model: product sales (direct-to-consumer and wholesale), licensing of IP, and strategic co-development agreements.
- Growth levers: expand distribution through strategic partnerships, broaden product pipeline into adjacent indications, and pursue licensing deals for proprietary technologies.
- Customer focus: continuous product improvement and support mechanisms designed to sustain high satisfaction and repeat usage.
| Metric | Value |
|---|---|
| Annual R&D spend | $1.2 million |
| R&D as % of revenue | ~15% |
| Estimated annual revenue | ~$8 million |
| Primary therapeutic targets | Hair loss, eczema, burns, sexual wellness |
| IP position | Diverse portfolio of granted and pending patents |
| Strategic focus | Partnerships, licensing, product pipeline expansion |
- Strategic approach: form alliances with industry leaders for distribution, co-development, and clinical validation to accelerate market penetration.
- Customer commitment: iterative product refinement informed by user feedback and clinical evidence to maintain high satisfaction levels.
Jupiter Wellness, Inc. (JUPW) - How It Works
Jupiter Wellness operates as an R&D-driven developer of over-the-counter (OTC) health and wellness products and associated intellectual property, focusing on underserved therapeutic and consumer wellness niches.- Core operating model: in-house research and formulation + outsourced manufacturing and distribution partnerships.
- Primary activities: preclinical and clinical testing, product formulation, IP prosecution, regulatory compliance, and commercialization/licensing.
| Metric | Value (most recent fiscal) |
|---|---|
| Reported R&D spend | $1,200,000 |
| R&D as % of revenue | ~15% |
| Implied annual revenue | ~$8,000,000 |
| Granted patents | 12 |
| Patents pending | 18 |
- Target conditions: hair loss, eczema, burns (topical regenerative therapies), and sexual wellness formulations.
- Product types: OTC topical treatments, consumer wellness supplements, and novel formulation IP for licensing.
- Direct sales of OTC and consumer products through retail and e-commerce.
- Contract research agreements and fee-for-service formulation work.
- Licensing royalties and milestone payments from partners commercializing Jupiter Wellness IP.
- Diverse portfolio of granted and pending patents to protect formulations, delivery systems, and novel actives.
- Monetization strategy includes exclusive and non‑exclusive licenses, joint development agreements, and royalty-bearing commercialization deals.
- Forms alliances with established organizations in wellness, clinical research, and distribution to accelerate market entry and validate scientific claims.
- Leverages contract manufacturers and retail channels to scale without heavy capital expenditure.
Jupiter Wellness, Inc. (JUPW): How It Makes Money
Jupiter Wellness monetizes its R&D and product development across OTC, consumer health, contract research and licensing, leveraging partnerships and geographic expansion to amplify revenue.- Direct sales of OTC and consumer products across dermatology, pain relief and nutritional supplement categories.
- Contract research agreements and development services for third parties (fee-for-service revenue).
- Licensing royalties and milestone payments from partners who commercialize Jupiter's formulations and delivery technologies.
- Strategic co-development and distribution partnerships that provide upfront/recurring payments and market access.
- Notable partner: Taisho Pharmaceutical - a ~ $2.6 billion revenue company - licensed Jupiter's Minoxidil Booster product, illustrating the scale-up and royalty model potential.
- International rollout: Photocil has been licensed abroad and is being launched commercially in India, expanding Jupiter's addressable market and royalty pipelines.
| Revenue/Value Driver | Role | Commercial Status / Notes |
|---|---|---|
| OTC & consumer product sales | Recurring product revenue | Dermatology, pain relief, supplements - direct-to-consumer and retail channels |
| Contract research & development | Service revenue | Fee-based contracts supporting external formulation and testing |
| Licensing & royalties | High-margin, scalable revenue | Taisho (Minoxidil Booster) license; Photocil licensed internationally; India commercial launch underway |
| Partnerships & distribution | Market access and milestone payments | Strategic collaborations to accelerate commercialization and expand geographies |
| Financial health indicators | Capital and sustainability risks | SEC filings report accumulated deficits and operating cash flow usage, indicating continued need for capital and successful commercialization to achieve profitability |

Jupiter Wellness, Inc. (JUPW) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.